Liquan Zhu

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A Single-Amino-Acid Ligand for LAT1: A Minimalist and Modular Platform for Lysosome-Targeted Degradation of Membrane Proteins.

A Single-Amino-Acid Ligand for LAT1: A Minimalist and Modular Platform for Lysosome-Targeted Degradation of Membrane Proteins.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 06, 2026

Dual-mode fluorescence and UV-vis aptasensor for hepatocellular carcinoma detection using magnetic separation.

Dual-mode fluorescence and UV-vis aptasensor for hepatocellular carcinoma detection using magnetic separation.

Journal: Mikrochimica acta

Published: May 01, 2026

Aptamer-based fluorescence "off-on" sensor for EGFR-positive lung cancer CTCs using streptavidin magnetic beads and N-CQDs@Ag⁺.

Aptamer-based fluorescence "off-on" sensor for EGFR-positive lung cancer CTCs using streptavidin magnetic beads and N-CQDs@Ag⁺.

Journal: Mikrochimica acta

Published: April 28, 2026

Poria cocos-derived exosome-like nanoparticles ameliorate lymphedema by reprogramming fibroblast metabolism via enhanced TCA cycle flux.

Poria cocos-derived exosome-like nanoparticles ameliorate lymphedema by reprogramming fibroblast metabolism via enhanced TCA cycle flux.

Journal: Journal of nanobiotechnology

Published: December 24, 2025

Cation homeostasis-related prognostic genes uncovered by transcriptomic analysis in breast cancer.

Cation homeostasis-related prognostic genes uncovered by transcriptomic analysis in breast cancer.

Journal: Translational cancer research

Published: December 17, 2025

Z-Guggulsterone Inhibits Triple-Negative Breast Cancer Progression by Blocking Autophagosome-Lysosome Fusion via OGT-Mediated SNAP29 O-GlcNAcylation.

Z-Guggulsterone Inhibits Triple-Negative Breast Cancer Progression by Blocking Autophagosome-Lysosome Fusion via OGT-Mediated SNAP29 O-GlcNAcylation.

Journal: Phytotherapy research : PTR

Published: November 26, 2025

Development of glucagon-like Peptide-1 lysosomal targeting chimeras for degradation of extracellular and membrane proteins.

Development of glucagon-like Peptide-1 lysosomal targeting chimeras for degradation of extracellular and membrane proteins.

Journal: European journal of medicinal chemistry

Published: October 26, 2025

Corrigendum to "Engineered macrophages in breast cancer: bridging targeted therapy and advanced drug delivery" [Int. Immunopharmacol. 163 (2025) 115237].

Corrigendum to "Engineered macrophages in breast cancer: bridging targeted therapy and advanced drug delivery" [Int. Immunopharmacol. 163 (2025) 115237].

Journal: International immunopharmacology

Published: July 26, 2025

Engineered macrophages in breast Cancer: bridging targeted therapy and advanced drug delivery.

Engineered macrophages in breast Cancer: bridging targeted therapy and advanced drug delivery.

Journal: International immunopharmacology

Published: May 24, 2025

Pachymic acid alleviates secondary lymphedema through the modulation of EETs level and the inhibition of lymphatic fibrosis.

Pachymic acid alleviates secondary lymphedema through the modulation of EETs level and the inhibition of lymphatic fibrosis.

Journal: International immunopharmacology

Published: January 30, 2025

A site-specific fluorogenic probe for protein disulfide isomerase A1.

A site-specific fluorogenic probe for protein disulfide isomerase A1.

Journal: Analytical biochemistry

Published: December 29, 2024

Unveiling a new strategy for PDIA1 inhibition: Integration of activity-based probes profiling and targeted degradation.

Unveiling a new strategy for PDIA1 inhibition: Integration of activity-based probes profiling and targeted degradation.

Journal: Bioorganic chemistry

Published: February 07, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026